documents: FDA-2017-N-6716-0001

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2017-N-6716-0001 FDA FDA-2017-N-6716 New Insights for Product Development and Bioequivalence Assessments of Generic Orally Inhaled and Nasal Drug Products; Public Workshop; Request for Comments Notice Announcement 2017-12-19T05:00:00Z 2017 12 2017-12-19T05:00:00Z 2018-02-15T04:59:59Z 2018-02-15T02:03:48Z 2017-27279 0 0 0900006482d3ae6f

Links from other tables